These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17059753)

  • 1. Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass.
    Pérez G; Devaud N; Escalona A; Downey P
    Obes Surg; 2006 Oct; 16(10):1388-91. PubMed ID: 17059753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based review of ACE inhibitors in incipient diabetic nephropathy.
    Haider A; Oh P; Peloso PM
    Can J Clin Pharmacol; 2000; 7(2):115-9. PubMed ID: 10958708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy.
    How HY; Sibai BM
    J Matern Fetal Neonatal Med; 2002 Dec; 12(6):402-7. PubMed ID: 12683651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of diabetic nephropathy. Effects of ACE inhibition on microcirculation].
    Haak T; Haak E; Jungmann E; Kusterer K; Usadel KH
    Fortschr Med; 1997 Dec; 115(35-36):26-9. PubMed ID: 9499637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V
    Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric bypass and resolution of proteinuria in an obese diabetic patient.
    Izzedine H; Coupaye M; Reach I; Deray G
    Diabet Med; 2005 Dec; 22(12):1761-2. PubMed ID: 16401325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients.
    Tanaka M; Yamada S; Iwasaki Y; Sugishita T; Yonemoto S; Tsukamoto T; Fukui S; Takasu K; Muso E
    Nephron Clin Pract; 2009; 112(2):c71-8. PubMed ID: 19390205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early results of conversion of laparoscopic adjustable gastric band to Roux-en-Y gastric bypass.
    Moore R; Perugini R; Czerniach D; Gallagher-Dorval K; Mason R; Kelly JJ
    Surg Obes Relat Dis; 2009; 5(4):439-43. PubMed ID: 19342311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
    Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
    Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin B2 receptors as a target in diabetic nephropathy.
    Doggrell SA
    Curr Opin Investig Drugs; 2006 Mar; 7(3):251-5. PubMed ID: 16555685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute kidney injury after gastric bypass surgery.
    Thakar CV; Kharat V; Blanck S; Leonard AC
    Clin J Am Soc Nephrol; 2007 May; 2(3):426-30. PubMed ID: 17699447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.